Restorative Environments for Gait Therapy with VR
REGaitVR
Effectiveness of Restorative Landscape Environments in Virtual Reality (VR) Used in Gait Training to Improve Gait Performance and Affect Restoration in Older Adults with Gait Insecurity - a Pilot Randomized Controlled Trial
2 other identifiers
interventional
84
1 country
3
Brief Summary
The aim of our study is to investigate the effects of landscapes during gait therapy. The investigators will evaluate the impacts of restorative landscapes as they occur in urban, rural and forest environments. Older people will experience those landscapes using virtual reality (VR) goggles during their gait training. The investigators expect the landscapes to have an effect on the following three aspects: (1) stress reduction, (2) restoration of attention and (3) change in gait parameters. For this purpose, volunteers who are currently inpatient in one of our study centers and already participating in gait therapy will be assigned to a group. The control group will receive the standard therapy. The participants of the intervention groups will receive five additional VR training sessions to the standard therapy. In these sessions, the participants will walk through urban, rural and forest landscapes and perform balance improvement exercises. The five training sessions will take place within ten days. Allocation to the control or intervention groups and their landscapes is random. At the start and end of participation, tests defining stress levels and gait parameters are carried out so that comparisons can be made between before and after treatment. The goal of the study is to find out which type of landscape supports restoration and can therefore contribute to greater gait stability. The investigators expect that improved gait stability will be promoted by stress reduction and increased attention induced by the virtual environments. The investigators are investigating the consequences of repeated application of virtual landscapes and the relationship between the effect of the landscape and the preferences and habits of the study participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedStudy Start
First participant enrolled
April 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedMarch 11, 2025
March 1, 2025
1.4 years
February 26, 2024
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gait Stability
The German version of the Activities-specific Balance Confidence (ABC) Scale is used to assess balance self-confidence in older people. Self-report of fear of falling correlates with performance on the blindfolded and one-legged tests, and in addition, fear of falling can lead to activity limitation, resulting in a decline in physical performance. It has a 11-point response scale (no confidence 0% - 100% completely confident) and the overall score it calculated by summing the scores and dividing by the number of items (16). Cut-off scores are \< 50% (lower level of physical functioning), 50-80% (moderate level) and \> 80% (high level), a score smaller than 67% indicated a risk for falling. The ABC scale can be complected within 5-10 minutes.It could show an internal consistency of the ABC scale of 0.94 and a test-retest reliability of 0.85 (95% CI, 0.68, 0.93).
at day 0 and day 11
Secondary Outcomes (17)
Variability (Gait Parameter)
day 0 - 11
Speed (Gait Parameter)
day 0 - 11
Asymmetry (Gait Parameter)
day 0 - 11
Stance (Gait Parameter)
day 0 - 11
Max. Heel Clearance (Gait Parameter)
day 0 - 11
- +12 more secondary outcomes
Other Outcomes (7)
Age (Demographic data)
day 0
Height (Demographic data)
day 0
Weight (Demographic data)
day 0
- +4 more other outcomes
Study Arms (4)
forest
EXPERIMENTALvirtual reality (VR) assisted gait therapy in a forest landscape
urban
EXPERIMENTALvirtual reality (VR) assisted gait therapy in a urban landscape
rural
EXPERIMENTALvirtual reality (VR) assisted gait therapy in a rural landscape
control
NO INTERVENTIONstandard gait therapy
Interventions
Participants in the intervention groups will receive 5 VR training sessions over 10 days in addition to their usual care. Each participant will wear the HMD for 25 minutes in each of this training sessions, whereby he or she will first sit for 5 minutes looking at a forest-landscape. This is followed by 20 minutes of independent exploration of the virtual environment by walking. Depending on the user's gait stability, walking aids (such as walking sticks or rollators) may be used. This phase aims at keeping the participant walking.
Participants in the intervention groups will receive 5 VR training sessions over 10 days in addition to their usual care. Each participant will wear the HMD for 25 minutes in each of this training sessions, whereby he or she will first sit for 5 minutes looking at an urban-landscape. This is followed by 20 minutes of independent exploration of the virtual environment by walking. Depending on the user's gait stability, walking aids (such as walking sticks or rollators) may be used. This phase aims at keeping the participant walking.
Participants in the intervention groups will receive 5 VR training sessions over 10 days in addition to their usual care. Each participant will wear the HMD for 25 minutes in each of this training sessions, whereby he or she will first sit for 5 minutes looking at a rural-landscape. This is followed by 20 minutes of independent exploration of the virtual environment by walking. Depending on the user's gait stability, walking aids (such as walking sticks or rollators) may be used. This phase aims at keeping the participant walking.
Eligibility Criteria
You may qualify if:
- age: \> 65 years
- german-speaking
- ability to give informed consent
- attends gait safety training (usual care)
- inpatient for a duration of min. 2 weeks in one of the study sites
- items 7 - 15 of the De Morton Mobility Index (DEMMI): min. 2 points, max. 9 points
- minute walking distance: \> 30 m without rest, with or without walking aids, overground walking on flat surface
You may not qualify if:
- epilepsy
- Partial weight bearing or conservatively or surgically treated billing with weight bearing as determined by symptoms
- Severe hearing impairment (if not corrected with hearing aid)
- Injuries to the eyes, face, or neck that prevent comfortable use of VR glasses.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ETH Zurichlead
Study Sites (3)
Spitäler Schaffhausen
Schaffhausen, Canton of Schaffhausen, 8208, Switzerland
Geriatrische Klinik St. Gallen
Sankt Gallen, Canton of St. Gallen, 9000, Switzerland
Spital Zollikerberg
Zollikerberg, Canton of Zurich, 8125, Switzerland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ulrike Wissen Hayek, Dr.
ETH Zürich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2024
First Posted
March 12, 2024
Study Start
April 23, 2024
Primary Completion
August 31, 2025
Study Completion
August 31, 2025
Last Updated
March 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share